Market Overview

A Peek Into The Market Before The Trading Starts

A Peek Into The Market Before The Trading Starts
Related BSX
Earnings Scheduled For April 27, 2017
Global Market For Medical Implants To Hit Nearly $27 Billion In 5 Years
Related MA
What Does The China Trade Deal Mean For Financial, Beef And Poultry Players?
The Top 11 Analysts On TipRanks And What They Cover
Stock Indexes Rise To New Highs; Visa, Mastercard Up (Investor's Business Daily)

Pre-open movers US stock futures are lower this morning, as investors are awaiting economic data. Futures for the Dow Jones Industrial Average dropped 20 points to 13,413.00 and S&P 500 index futures fell 3.60 points to 1,460.70. Nasdaq 100 futures declined 5 points to 2,723.75.

A Peek Into Global Markets European markets were mostly lower today. The STOXX Europe 600 Index fell 0.03%, London's FTSE 100 Index gained 0.05%, German DAX 30 Index dropped 0.21% and French CAC 40 Index fell 0.23%.

Asian markets ended mostly higher, with Japan's Nikkei Stock Average rising 0.72%, China's Shanghai Composite jumping 0.60% and Australia's S&P/ASX 200 Index dropping 0.06%. Hong Kong's Hang Seng Index fell 0.14% and India's Sensex surged 0.40%.

Broker Recommendation Analysts at Credit Suisse upgraded Boston Scientific (NYSE: BSX) from “neutral” to “outperform.” The target price for Boston Scientific has been raised from $6 to $7.50.

Boston Scientific shares dropped 0.63% to close at $6.32 yesterday.

Breaking news

  • MasterCard (NYSE: MA) and Equity Bank of Kenya today announced an agreement at a signing ceremony in Nairobi to issue five-million MasterCard-branded debit and prepaid cards, over the next 18 months. To read the full news, click here.
  • Lennar (NYSE: LEN) reported upbeat fourth-quarter profit. To read the full news, click here.
  • As organizations of all types look to accelerate the adoption of video-based communications and video-enabled business processes, AT&T (NYSE: T) and Polycom (NASDAQ: PLCM) announced today a strategic agreement to personalize, mobilize and virtualize video meetings. To read the full news, click here.
  • Pluristem Therapeutics (NASDAQ: PSTI) announced today that the Paul-Ehrlich-Institute (PEI), the medical regulatory body for biological medicinal products for the Federal Republic of Germany, has approved the company's request to initiate a Phase II study using PLX-PAD cells in patients suffering from Intermittent Claudication (IC). To read the full news, click here.

Posted-In: Credit Suisse US Stock FuturesNews Futures Global Pre-Market Outlook Markets


Related Articles (BSX + LEN)

View Comments and Join the Discussion!